3-17161013-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001349074.2(TBC1D5):c.2404G>A(p.Asp802Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001349074.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D5 | NM_001349074.2 | c.2404G>A | p.Asp802Asn | missense_variant | 23/23 | ENST00000696125.1 | NP_001336003.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D5 | ENST00000696125.1 | c.2404G>A | p.Asp802Asn | missense_variant | 23/23 | NM_001349074.2 | ENSP00000512418 | P2 | ||
ENST00000649558.1 | n.698+5521C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251308Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135828
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727230
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2021 | The c.2404G>A (p.D802N) alteration is located in exon 24 (coding exon 21) of the TBC1D5 gene. This alteration results from a G to A substitution at nucleotide position 2404, causing the aspartic acid (D) at amino acid position 802 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at